XUZHOU,china, Jan. 26, 2025 /PRNewswire/ — Recently, with the successful completion of the UAV patrol on the Xuzhou Tongshan Jiao third line, State Grid Xuzhou Power Supply Company has achieved its first comprehensive UAV patrol of distribution lines. Since last year, the company has implemented a rigorous closed-loop control system for drone operations, encompassing pre-flight planning, real-time flight progress monitoring, post-flight quality verification, and defect elimination. This systematic approach has been applied to 2,126 scheduled flights covering all operational distribution lines, ensuring a thorough “carpet-style” inspection.
The patrol focused on identifying critical issues such as tree-line conflicts, channel obstructions, foreign objects, aged connection points, discharge traces, and structural fractures that could compromise the reliable operation of distribution lines and equipment. A comprehensive quality assurance process was established to verify the accuracy and completeness of patrol data, including work order submissions, data integrity, photo standards, and defect identification. This process ensures optimal UAV patrol outcomes and promotes continuous improvement in patrol quality.
Additionally, the company is developing a UAV patrol defect database to facilitate a closed-loop workflow of “precise patrol + targeted defect elimination.” Defects are categorized based on severity, enabling maintenance personnel to prioritize corrective actions effectively. This initiative enhances the overall reliability of the distribution network.
Looking ahead, State Grid Xuzhou Power Supply Company plans to enhance personnel training and explore innovative patrol modes such as adaptive flying and live detection patrols. These efforts aim to further improve patrol efficiency and quality, supporting the city’s distribution network development.


Đề xuất
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
ZTO Express to Hold Annual General Meeting on June 16, 2026